Horizon Discovery Group (LON:HZD)‘s stock had its “hold” rating reiterated by research analysts at Peel Hunt in a report issued on Tuesday.

Shares of LON HZD opened at GBX 168.25 ($2.20) on Tuesday. Horizon Discovery Group has a fifty-two week low of GBX 128 ($1.67) and a fifty-two week high of GBX 252 ($3.29).

Horizon Discovery Group Company Profile

Horizon Discovery Group plc, an integrated life science company, designs, manufactures, and applies gene editing and gene modulation to build cell models that harbour the genetics of human disease in the Americas, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company operates through Products, Services, and Leveraged Research and Development (R&D) segments.

Featured Story: Google Finance Portfolio Workaround

Receive News & Ratings for Horizon Discovery Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Horizon Discovery Group and related companies with MarketBeat.com's FREE daily email newsletter.